Clinical Trial Update: Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia [Phase 1, Phase 2]

View source ↗

Summary

This is an ongoing Phase 1/2 clinical trial evaluating the safety and feasibility of cord blood–derived mesenchymal stem cells for treating pneumonia related to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Cord Blood Derived Mesenchymal Stem Cells

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: RECRUITING